Elanco Animal Health Incorporated announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 1,279 million compared to USD 586 million a year ago. Net loss was USD 210 million compared to USD 53 million a year ago. Basic loss per share from continuing operations was USD 0.43 compared to USD 0.13 a year ago. For the half year, sales was USD 2,521 million compared to USD 1,244 million a year ago. Net loss was USD 271 million compared to USD 102 million a year ago. Basic loss per share from continuing operations was USD 0.56 compared to USD 0.25 a year ago.